About C. Guyer
Greg Guyer, Ph.D., joined BioMarin in May 2020 and serves as its Chief Technical Officer and Executive Vice President. In a September 2023 appearance, Guyer described the company as being "founded on just unbelievably strong science" and "on this kind of cusp of the next generation of breakthrough products." He noted that senior leaders in the organization participate directly in research and development work, including viral vector efforts, to gain intimate understanding of products from their inception.
Guyer stated that this "scientific acumen" is a "critical foundational skill" that creates "seamlessness from R&D into the process development into our commercial manufacturing," which he said gives the company "a lot higher probability of success." He previously worked at the FDA and at Bristol Myers Squibb, where he said he developed an interest in new technologies.
Source: AI-verified profile updated from C. Guyer's recent appearances.
Browse all interviews →
Transcript (1 segments)
C
C. Guyer0:02
I started off my career at FDA, did a lot of work at MC, and then I went to Bristol Myers Squibb because I was interested in new technologies. I have an infectious desire to continue to learn. I'm Greg Guyer, I'm the Chief Technical Officer. This company is founded on unbelievably strong science. We are on the cusp of the next generation of breakthrough products. You can see it coming to life. We have people that are in the top of the organization sitting in R&D, actually helping with some of the viral vector work, truly understanding things at the very inception, so that when that product comes through they understand it intimately well. That scientific acumen is such a critical foundational skill. It really drives a seamlessness from R&D into process development into our commercial manufacturing, which gives us a much higher probability of success.
